Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -87.56%344.91K | 591.47%3.94M | 60.73%-1.05M | -81.73%-943.16K | 19.63%-2.08M | 798.69%2.77M | -794.49%-802.13K | 36.76%-2.69M | 63.79%-518.99K | 27.17%-2.59M |
| Net income from continuing operations | -108.67%-16.51K | 118.14%365.95K | 76.89%-2.46M | -64.60%-1.12M | 109.36%483.45K | 108.12%190.45K | 18.11%-2.02M | -24.95%-10.65M | 84.45%-679.39K | -338.39%-5.16M |
| Operating gains losses | 83.39%-116.52K | -308.92%-304.17K | -161.85%-1.46M | -144.77%-618.48K | -132.26%-283.98K | -1,637.96%-701.53K | 187.48%145.59K | 536.83%2.36M | 1,505.84%1.38M | 333.50%880.19K |
| Depreciation and amortization | 30.53%411.71K | 48.90%498.19K | -12.35%1.36M | -9.36%376.4K | -0.38%329.81K | -13.16%315.41K | -23.56%334.59K | -0.61%1.55M | 13.14%415.25K | -28.06%331.07K |
| Asset impairment expenditure | --0 | --0 | --410K | --0 | --0 | --0 | --410K | --0 | -2,848.94%-1.37M | --1.37M |
| Remuneration paid in stock | 415.76%350.15K | 96.47%144.78K | 7.22%366.89K | 120.15%140.97K | 1.20%84.34K | -38.88%67.89K | -12.00%73.69K | -31.86%342.19K | -51.13%64.03K | -27.62%83.34K |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non cashItems | 2.98%686.29K | -2.58%573.83K | -38.51%2.05M | 164.24%80.11K | -49.45%713.89K | -37.02%666.47K | -40.32%589K | -3.03%3.33M | -108.46%-124.7K | 59.01%1.41M |
| Change In working capital | -125.81%-716.23K | 4,828.14%2.97M | -99.57%11.37K | 100.02%124 | -2,819.55%-2.7M | 60.97%2.78M | -103.83%-62.88K | 46.11%2.65M | -128.51%-622.31K | 96.76%-92.52K |
| -Change in receivables | -758.30%-2.6M | 183.00%1.09M | -13.38%-1.91M | 59.72%-943.2K | -112.84%-44.33K | -54.00%395.32K | -140.67%-1.32M | -182.36%-1.68M | -740.62%-2.34M | -78.11%345.27K |
| -Change in inventory | -64.79%969.36K | 63.16%1.41M | -43.73%3.08M | -57.88%477.38K | -161.16%-1.01M | 105.25%2.75M | -35.71%865.04K | 171.56%5.48M | -55.38%1.13M | 203.52%1.66M |
| -Change in prepaid assets | -59.83%25.62K | -12.13%-174.04K | 125.69%154.95K | 125.87%157.31K | 222.25%89.06K | -78.54%63.79K | 29.30%-155.21K | -1,533.98%-603.13K | -540.12%-607.98K | -181.08%-72.85K |
| -Change in payables and accrued expense | 303.85%891.16K | 17.69%641.73K | -144.28%-1.32M | -74.15%308.64K | 14.34%-1.73M | 43.52%-437.17K | -48.73%545.27K | 76.48%-538.54K | 238.73%1.19M | 30.74%-2.02M |
| Interest paid (cash flow from operating activities) | 53.03%-253.97K | -12.78%-309.41K | 41.36%-1.33M | -453.08%-334.85K | 83.65%-178.52K | 16.47%-540.68K | 55.85%-274.35K | -3.03%-2.27M | 111.46%94.84K | -77.77%-1.09M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -87.56%344.91K | 591.47%3.94M | 60.73%-1.05M | -81.73%-943.16K | 19.63%-2.08M | 798.69%2.77M | -794.49%-802.13K | 36.76%-2.69M | 63.79%-518.99K | 27.17%-2.59M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 71.47%-43.15K | -582.69%-100.64K | -105.73%-189.97K | -100.58%-18.82K | 88.29%-5.2K | -202.60%-151.22K | 1.48%-14.74K | 1,223.55%3.31M | 4,705.29%3.23M | 68.11%-44.38K |
| Net PPE purchase and sale | 65.05%-57.63K | -358.16%-114.92K | -499.04%-242K | -20.09%-32.91K | -113.14%-19.09K | -290.14%-164.91K | -67.64%-25.08K | 120.56%60.65K | 64.30%-27.4K | 209.69%145.28K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.25M | ---- | ---- |
| Net other investing changes | 5.75%14.49K | 38.14%14.29K | --52.02K | --14.09K | --13.89K | --13.7K | --10.34K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 71.47%-43.15K | -582.69%-100.64K | -105.73%-189.97K | -100.58%-18.82K | 88.29%-5.2K | -202.60%-151.22K | 1.48%-14.74K | 1,223.55%3.31M | 4,705.29%3.23M | 68.11%-44.38K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 88.49%-301.76K | -570.28%-3.84M | 298.20%1.24M | 135.53%961.98K | -20.78%2.09M | -475.04%-2.62M | 912.51%816.87K | -113.83%-628.15K | -280.09%-2.71M | -28.71%2.64M |
| Net issuance payments of debt | 93.85%-301.76K | -631.49%-4.34M | 88.90%-1.04M | 135.53%961.98K | 134.28%2.09M | -975.77%-4.91M | 912.51%816.87K | -305.91%-9.35M | -280.09%-2.71M | -264.72%-6.09M |
| Net common stock issuance | ---- | ---- | -74.39%2.28M | --0 | --0 | ---- | ---- | --8.92M | --0 | --8.92M |
| Net other financing activities | --0 | --500K | ---- | ---- | ---- | ---- | ---- | ---190.1K | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 88.49%-301.76K | -570.28%-3.84M | 298.20%1.24M | 135.53%961.98K | -20.78%2.09M | -475.04%-2.62M | 912.51%816.87K | -113.83%-628.15K | -280.09%-2.71M | -28.71%2.64M |
| Net cash flow | ||||||||||
| Beginning cash position | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| End cash Position | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Free cash from | -88.99%287.27K | 562.68%3.83M | 54.25%-1.3M | -78.64%-976.07K | 20.84%-2.1M | 879.41%2.61M | -922.80%-827.21K | 37.60%-2.84M | 63.66%-546.39K | 28.18%-2.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.